Down 75%. Is Agenus Stock a Buy on the Dip?
Agenus(AGEN) The Motley Fool·2024-04-08 07:34Wall Street analysts who watch the cancer drug developer closely think it could rocket higher.The past nine months have been rough ones to be an Agenus (AGEN -0.43%) shareholder. The stock has collapsed by about 75% from the peak it set last June.Investment bank analysts on Wall Street who follow the Massachusetts-headquartered cancer drug developer think it's been underappreciated. For example, B. Riley recently reiterated a buy rating for Agenus with a $5 price target.Agenus shares could deliver an enormo ...